Uric acid and chronic kidney disease: A time to act?

doi:10.5527/wjn.v2.i2.17

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6475)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-5) series.

Item

Count

PDF

459

HTML

3821

Tables (1-5)

246

Sum=4526

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

976

Download

970

Sum=1946

May 6, 2013 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Nephrol. May 6, 2013; 2(2): 17-25
Published online May 6, 2013. doi: 10.5527/wjn.v2.i2.17

Table 4 Urate lowering drugs

Pharmacologic options for the treatment of hyperuricemia

Xanthine-oxidase inhibitors: Allopurinol, febuxostat

Uricosuric agents: Probenecid, sulfinpyrazone, benzbromarone

Uricase: Rasburicase, pegloticase

Drugs and contrast media with hypouricemic properties, not primarily intended for the treatment of hyperuricemia

Acetohexamide, azauridine, chlorprothixene, dicumarol, estrogens, fenofibrate, glyceryl guaiacolate, iopanoic acid, losartan,meglumine iodapamide, phenylbutazone, salicylates and other NSAIDs, sodium diatrizoate, trimetoprim-sulfamethoxazole

NSAIDs: Nonsteroidal anti-inflammatory drugs.

Citation: Bellomo G. Uric acid and chronic kidney disease: A time to act? World J Nephrol 2013; 2(2): 17-25
URL: https://www.wjgnet.com/2220-6124/full/v2/i2/17.htm
DOI: https://dx.doi.org/10.5527/wjn.v2.i2.17